deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT03340727

Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial (MoCHA)

Randomized Controlled Trial of Home Therapy With Caffeine Citrate in Moderately Preterm Infants With Apnea of Prematurity

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Updated 19 times since 2017 Last updated: Jul 30, 2024 Started: Feb 27, 2019 Primary completion: Jan 23, 2023 Completion: Mar 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Futility

Listed as NCT03340727, this PHASE3 trial focuses on Apnea of Prematurity and remains terminated or withdrawn. Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), it has been updated 19 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Apr 2019 · 9 months · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~May 2020 · 6 months · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Oct 2020 · 4 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~Mar 2023 · 13 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

19 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Aug 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Aug 2024 [monthly]

    Terminated PHASE3

    Status: Active Not RecruitingTerminated

  4. Mar 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  5. Feb 2022 — Mar 2023 [monthly]

    Recruiting PHASE3

Show 14 earlier versions
  1. Oct 2021 — Feb 2022 [monthly]

    Recruiting PHASE3

  2. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  3. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  4. Jun 2020 — Oct 2020 [monthly]

    Recruiting PHASE3

    Status: Active Not RecruitingRecruiting

  5. May 2020 — Jun 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  6. Nov 2019 — May 2020 [monthly]

    Recruiting PHASE3

  7. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE3

  8. Aug 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  9. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE3

  10. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  11. Apr 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  12. Jul 2018 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE3

  13. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE3

  14. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • NICHD Neonatal Research Network
Data source: NICHD Neonatal Research Network

For direct contact, visit the study record on ClinicalTrials.gov .